Digestive Disease Institute. Clinical Research. Discovering New Ways to Diagnose and Treat Digestive Diseases

Similar documents
PATIENT BROCHURE. 441 Charmany Dr 1 Madison WI, RX Only

FREQUENTLY ASKED QUESTIONS

2017 CANCER ANNUAL REPORT

Epi procolon 2.0 CE is a blood test for colorectal cancer screening.

What a history of cancer may mean for you and your family and the steps you can take to reduce the risk

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696

12: BOWEL CANCER IN FAMILIES

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

Outcomes. Digestive Disease Center

Rx Only. Detecting Cancer In Blood.

Laparoscopic Surgical Approaches for Ulcerative Colitis

Citation for published version (APA): Bartels, S. A. L. (2013). Laparoscopic colorectal surgery: beyond the short-term effects

Colorectal Cancer How to reduce your risk

CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING

Pathology reports, related operative reports and consult letters must be provided with a request for assessment.

1101 First Colonial Road, Suite 300, Virginia Beach, VA Phone (757) Fax (757)

Wireless Capsule Endoscopy as a Diagnostic Technique in Disorders of the Small Bowel, Esophagus and Colon Corporate Medical Policy

Digestive Disease Institute Outcomes

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013

LET S TALK ABOUT CANCER

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018

2012 update. Bowel Cancer. Information for people at increased risk of bowel cancer. Published by the New Zealand Guidelines Group

Surgery for Inflammatory Bowel Disease

Thirty-Day Outcomes of Laparoscopic vs. Open Total Proctocolectomy with Ileoanal Anastomosis in Children

[Type here] CG [Type here]

YES NO UNKNOWN. Stage I: Rule-Out Dashboard ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above)

Hereditary Colorectal Cancer

Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 4: Colorectal Cancer Overview

Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population

Quality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction

Index. Note: Page numbers of article title are in boldface type.

19th Annual International Colorectal Disease Symposium An International Exchange of Medical and Surgical Concepts

Inflammatory Bowel Disease and Surgery: What You Should Know

Audio-digest: Internal Medicine: Colon Cancer/GI Update (Vol. 49, Issue 20, October 21, 2002) By MD Timothy T. Nostrant;MD Neil Stollman READ ONLINE

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University

Homayoon Akbari, MD, PhD

Razvan I. Arsenescu, MD Assistant Professor of Medicine Division of Digestive Diseases EARLY DETECTION OF COLORECTAL CANCER

Advanced colon cancer icd 10

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

EARLY DETECTION OF COLORECTAL CANCER. Epidemiology of CRC

Outcomes. Digestive Disease Institute

Program Schedule Template Monday, February 23, 2015 Time Topic 7:00 a.m. Registration and Continental Breakfast 7:30 a.m. Welcome and Introductions

Supporting people at higher risk of bowel cancer

COPYRIGHTED MATERIAL. Contents. List of contributors Acknowledgements. 1 Stomas: The Past, Present and Future 1 Jennie Burch.

Inflammatory Bowel Diseases Clinic

Surgical Therapies for the Treatment of IBD!

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011

GENERAL COLORECTAL CANCER INFORMATION. What is colorectal cancer?

Colorectal Surgery. Patient Care. Goals and Objectives

Familial and Hereditary Colon Cancer

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

Angie Perrin Lead Nurse/Clinical Nurse Specialist Oxford Radcliffe Hospitals NHS Trust

This is the portion of the intestine which lies between the small intestine and the outlet (Anus).

GI EMERGENCIES Acute Abdominal Pain

Index. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type.

Understanding Your Genetic Test Result. Positive for Two Copies of an MYH Mutation

11/13/11. Biologics for CD and CUC: The Impact on Surgical Outcomes. Principles of Successful Intestinal Surgery

DIVISION OF GASTROENTEROLOGY

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Metastatic Colorectal Cancer

Colectomy. Surgical treatment for Ulcerative Colitis (UC) and Familial Adenomatous Polyposis (FAP) Patient and Family Education

Fast Track to FluFIT: Develop a FluFIT Workflow Amber Rogers, RN, MSN Mountain-Pacific Quality Health

Gastrointestinal Hemorrhage, Lower

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

Ostomy A to Z From the Phoenix Magazine March 2010 & Robyn Home, RGN, BSN, WOCN, DMU

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Colorectal Cancer Screening. Dr Kishor Muniyappa 2626 Care Drive, Suite 101 Tallahassee, FL Ph:

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

The role of Surgery and Stomas in IBD

Colorectal Cancer Screening

Bleeding in the Digestive Tract

PENETRANCE ACTIONABILITY SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above) YES (Proceed to Stage II)

Alabama Breast and Cervical Cancer Early Detection Program (ABCCEDP) County Health Department Protocol

How to Screen a patient with a Family History of Adenoma(s)

Colostomy & Ileostomy

Metastatic Colorectal Cancer

Colorectal Cancer Screening Guideline Issue Brief Updated May 30 th, 2018

Understanding Liver Disease

Familial and Hereditary Colon Cancer

Prevention of Bowel Cancer: which patients do I send for colonoscopy?

Pathology perspective of colonic polyposis syndromes

Digestive Disease Institute Outcomes

Surgery and Stomas in IBD When do I need it? Can I avoid it? How do I live with it?

8 th Congress of ECCO

Ileoanal Pouch Solves the Problem

Irritable Bowel Syndrome - The Way Out By Dr Paul Froomes READ ONLINE

Treatments for Fecal Incontinence A Review of the Research for Adults

Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D.

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Testimony Submitted by: Eric Zuckerman, DO Bloomfield Hill, MI Board Chairman, Pediatric IBD Foundation

Cancer Prevention and Early Detection Worksheet for Men

PREPARING FOR ANORECTOAL MANOMETRY. ManoScan Anorectal Manometry System

Inflammatory Bowel Disease: Updates and Controversies CASE #1 CASE #1 8/6/2015. What is the most likely diagnosis?

ASGE and AGA Issue Consensus Statement on Surveillance and Management of Dysplasia in Patients With Inflammatory Bowel Disease

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health

Colorectal Cancer Screening and Risk Assessment Workflow. Documentation Guide for Health Center NextGen Users

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2

Transcription:

Digestive Disease Institute Clinical Research Discovering New Ways to Diagnose and Treat Digestive Diseases

What Is A Clinical Trial? A clinical trial is a scientific study designed to assess whether a new procedure is better than standard therapy, to compare the value of two standard treatments, or to assess the safety and effectiveness of an experimental therapy. A clinical trial is not an experiment. The medication or treatment must first be found useful and safe in animals. Testing in humans is allowed only on volunteers who understand and accept the risks and benefits of participating in a study ( informed consent ). Volunteers may choose to leave a study at any time. Clinical trials may be conducted by a single physician, small group of physicians, single institution or many institutions nationally or internationally. Financial support for a clinical trial is normally provided by organizations such as the National Institutes of Health or a pharmaceutical company or device manufacturer. Also, Cleveland Clinic funds many of its own clinical trials. At Cleveland Clinic, an ethical oversight group known as the Institutional Review Board reviews each written research plan and may request adjustments be made before patients can be recruited for a clinical trial. Why Participate In A Clinical Trial? Participants can play a more active role in their own healthcare, gain access to new research treatments before they are widely available and help others by contributing to clinical research trials.

Examples of recent clinical trials that have lead to changes in patient care at Cleveland Clinic include a study of the stapled hemorrhoidectomy for prolapsed hemorrhoids, a technique that has been incorporated into our overall approach to treating hemorrhoids. Similarly, a series of other clinical trials led to the development of a Pouch Disorder Classification system, which has since been used worldwide for patient care management. How To Begin A large number of clinical trials is ongoing in Cleveland Clinic s Digestive Disease Institute at all times. If you qualify for a clinical trial, your physician will explain why you might want to participate. In all cases, the procedure, technique, device or drug under investigation, and details of what your participation will require, will be carefully explained to you. Enrollment will take place only after you have given consent. You can be assured that every clinical trial has been approved by the Cleveland Clinic Institutional Review Board and complies with federal regulations regarding patient privacy. Many patients welcome the opportunity to participate in a project designed to benefit patient care. However, if you are uncomfortable participating, simply say no thanks. It will not affect the care you receive at Cleveland Clinic in any way. To learn more about the clinical trials offered by Cleveland Clinic s Digestive Disease Institute or to see if you qualify for participation, please call 216.636.5340. Visit us online at clevelandclinic.org/dditrials.

Selected Registries and Databases Cleveland Clinic s Digestive Disease Institute is a world leader in the creation and maintenance of healthcare registries and databases. The use of state-of-the-art information gathering methods enables physician-researchers to track patients over time and assess the long-term impact of treatment on health and quality of life. Colorectal Cancer Database (established 1975) Included: Patients treated for colorectal cancer Goal: To provide information in the search for new diagnostic and treatment options David G. Jagelman Inherited Colorectal Cancer Registries (established 1979) Included: Family members of patients diagnosed with familial adenomatous polyposis (FAP), Puetz-Jeghers syndrome (PJS), juvenile polyposis (JP) and hereditary non-polyposis colon cancer (HNPCC) Goal: To alert family members at high risk for disease and encourage them to be screened Intestinal Rehabilitation Database (established 2002) Included: Patients diagnosed with short bowel or intestinal failure Goal: To track medical, surgical and nutritional history of patients to determine best course of treatment Irritable Bowel Disease DNA Database (established 2004) Included: Patients diagnosed with either Crohn s Disease or Ulcerative Colitis Goal: Identify underlying genetic factors of these diseases to allow better treatment for IBD patients Laparoscopic Database (established 1991) Included: Patients undergoing laparoscopic procedures Goal: To enhance patient care by tracking the success of these procedures Pelvic Floor Database (established 2007) Included: Patients seen at the Colorectal Center for Functional Bowel Disorders Goal: To improve functionality and quality of life Pelvic Pouch Database (established 1983) Included: Patients undergoing pelvic pouch surgery (ileal pouch, anal anastomosis) Goal: To evaluate long-term pouch function and quality of life Ripka Family Database for Crohn s Disease Research (established 2001) Included: Patients being treated for Crohn s disease Goal: To identify optimal treatment options

Of the top digestive disease centers in the United States, the Cleveland Clinic Digestive Disease Institute (DDI) is the first of its kind to unite all specialists in gastroenterology and hepatology, colorectal surgery, hepato-pancreato-biliary and transplant surgery, and nutrition services within one unique, fully integrated model of care aimed at optimizing the patient experience. Our institute is dedicated to finding newer, more effective ways to treat diseases of the digestive system. This is primarily accomplished by evaluating new techniques and protocols in clinical trials (also called clinical research studies). As a patient in our institute, you may be offered the opportunity to participate in a clinical trial. This brochure explains clinical trials, and tells you what you need to know in order to make an informed decision about participating.

08-DDI-011